Effects of Intelligent Parent-child Bonding Intervention on the Physical, Psychological and Social Health of Parents of Premature Infants During Hospitalization and Return Home
Launched by NATIONAL DEFENSE MEDICAL CENTER, TAIWAN · May 15, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special program designed to help parents of premature infants improve their physical, mental, and social well-being while their babies are in the hospital and after they go home. The program is called the "intelligent parent-child bonding intervention," and it aims to strengthen the connection between parents and their premature babies.
To be eligible for this study, parents must have a premature infant born before 37 weeks of pregnancy, be at least 20 years old, and be able to communicate in Mandarin or Taiwanese. It's important that they agree to participate and sign a consent form. The study is not yet recruiting participants, but if you join, you can expect to engage in activities that support your health and bond with your baby during this challenging time. It's also important to note that parents with certain conditions, like severe mental health issues or those who can't use mobile devices, won't be eligible to participate.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: 1. Parents of premature infants born less than 37 weeks of age; 2. Parents of premature infants aged 20 or above and able to communicate in Mandarin and Taiwanese; 3. Parents of premature infants agree to participate in this study and sign the research consent form; 4. The child is currently in the Pediatric and Neonatal Intensive Care Center
- • Exclusion Criteria: 1. The premature baby has congenital abnormalities or is in critical condition and cannot survive; 2. The parents cannot use mobile phones or other Internet devices; 3. The parents have a history of mental illness, intellectual disability or substance abuse.
About National Defense Medical Center, Taiwan
The National Defense Medical Center (NDMC) in Taiwan is a premier institution dedicated to advancing military and civilian healthcare through innovative research and clinical trials. As a leading sponsor of clinical studies, NDMC focuses on enhancing medical care for armed forces personnel and the general population by investigating new treatments and therapies. The center fosters collaboration among healthcare professionals, researchers, and military experts to address pressing health issues and improve patient outcomes. With a commitment to ethical standards and scientific excellence, NDMC plays a pivotal role in shaping the future of medical advancements in Taiwan and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported